Kevin Carroll

Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Eugenio Mercuri, Juan J. Vílchez, Odile Boespflug‐Tanguy et al. · The Lancet Neurology · 2024 · 100 citations

Duchenne Muscular Dystrophy, Clinical Trials, Pharmacotherapy +2

Large outbreak of verocytotoxin-producing<i>Escherichia coli</i>O157 infection in visitors to a petting farm in South East England, 2009

Chikwe Ihekweazu, Kevin Carroll, B Adak et al. · Epidemiology and Infection · 2011 · 52 citations · Full text

Vtec O157, Veterinary Microbiology, Bacterial Pathogens +18

The emerging importance of Shiga toxin-producing Escherichia coli other than serogroup O157 in England

Bhavita Vishram, Claire Jenkins, David R. Greig et al. · Journal of Medical Microbiology · 2021 · 42 citations · Full text

The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013–March 2017 and significance for clinical and public health

Kevin Carroll, Lisa Harvey-Vince, Claire Jenkins et al. · Journal of Medical Microbiology · 2019 · 20 citations

Wii-habilitation increases participation in therapy

Avinash Ramchandani, Kevin Carroll, Roel Buenaventura et al. · 2008 · 18 citations

Upright Posture, Physical Activity, Mental Health +22